Q 2 2021 P E RFO R MA N CE U P DAT E $69 $122 $0.42 $0.87 Q2 2021 – ORGANIC PERFORMANCE 4 Sales Adjusted Operating Income $870 $1,235 + 42% + 77% + 107% (1) (1) (1) Q2 2021 SEGMENT PERFORMANCE 5 CAI $488 $624 ($ in millions) SEM Distribution $54 $86 +28% +59% $239 $404 $15 $24 +69% +60% $159 $241 $17 $37 +52% +118% SPECIALTY EBITDA MARGIN EXPANSION 6 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 15.3% 15.2% 16.2% 18.5% 2018 2019 2020 YTD 2021 14.8% 15.2% 17.6% 19.1% 2018 2019 2020 YTD 2021 SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Masterbatch synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 7 Legacy CAI 18.9% 18.9% 20.3% 2019 2020 YTD 2021 Legacy 11.9% 13.8% 16.8% 2019 2020 YTD 2021 • Synergy capture translating to the bottom line • Positive mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 35% represents sales from products introduced in the last five years. ColorWorks innovation centers are specially designed to foster imagination and enable creative exploration of innovative solutions • Focus on customers’ sustainability initiatives through recyclability and post-consumer recycled materials for packaging applications • Supports 8-12% long-term revenue growth expectations across our sustainable solutions portfolio 8 2020 Pro forma $870 $69 Sustainable Solutions 66 37% 26 Healthcare 29 20% 7 Composites 12 36% 6 Growth in Asia / LATAM 47 39% 11 Other 190 48% 22 Sub-total $1,214 40% $141 COVID Response Applications (15) (8) FX Impact 36 4 Synergies 11 Incentives, Travel, Other Employee Costs (26) 2021 Actual $1,235 42% $122 Q2 2021 ORGANIC SALES AND OPERATING INCOME 9 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Sales Growth Rate Operating Income$ millions 10 Q2 2020PF Q2 2021 (2) Financial information is presented on a constant currency basis (1,2) (44% of total revenue) (56% of total revenue) Q2 END MARKET SALES PERFORMANCE +26% +38% +46% +103% +51% +9% +7% +67% Energy Telecom Building & Transportation Industrial Healthcare Packaging Consumer Q2 YEAR-OVER-YEAR EBITDA BRIDGE Q2 2020 Pro forma $ 106 Demand 69 11 EBITDA$ millions • Demand impact driven by growth in sustainable solutions and consumer products • Price increases more than offset raw material and supply chain impacts (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition CAI: Price / Mix 40 Inflation (32) SEM: Price / Mix 23 Inflation (18) Distribution: Price / Mix 81 Inflation (77) Net Price Benefit 17 Supply Chain Disruptions (14) COVID Response Applications (8) Synergies 11 Incentives, Travel, FX, Other (22) Q2 2021 Actual $ 159 Q1 2021 Actual $ 161 CAI: Price / Mix 32 Inflation (22) SEM: Price / Mix 15 Inflation (9) Distribution: Price / Mix 50 Inflation (48) Net Price Benefit 18 Supply Chain Disruptions (12) Demand / Seasonality (6) Other (2) Q2 2021 Actual $ 15912 EBITDA$ millions • Price increases more than offset raw material and freight inflation impacts • Demand impact driven by Q2 seasonality for the business Q1 TO Q2 SEQUENTIAL EBITDA BRIDGE Q 3 AN D FU LL Y EA R 2021 O U TLO O K $74 $98 $0.46 $0.68 ORGANIC GROWTH PROJECTIONS – Q3 14 Sales Adjusted Operating Income $925 $1,150 + 24% + 32% + 48% FULL YEAR GUIDANCE INCREASED 15 Sales Adj. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 23 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Other 2 2 2 2 3 3 3 4 3 4 4 5 5 5 5 5 6 7 27 e nt e nt ( xc l.

Refer to Attachment 7 Reconciliation of Non-GAAP Financial Measures for details regarding adjustments to previously reported results to arrive to the pro forma financial metrics. Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com 7 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2021 2020 2021 2020 Sales $ 1,201.5 $ 997.0 $ 4,818.8 $ 3,242.1 Operating Income 74.0 65.0 381.2 189.3 Net income from continuing operations attributable to Avient shareholders 29.8 74.2 230.8 132.0 Basic earnings per share from continuing operations attributable to Avient shareholders $ 0.33 $ 0.81 $ 2.53 $ 1.47 Diluted earnings per share from continuing operations attributable to Avient shareholders $ 0.32 $ 0.81 $ 2.51 $ 1.46 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. See Attachment 3 for a definition and summary of special items and Attachment 7 for a summary of pro forma adjustments associated with the Clariant Color Acquisition necessary to reflect Clariant Color adjusted results in all periods presented.

Antitrust Laws 2 Antitrust Law Violations 3 Antitrust Potential Areas of Concern 3 Conclusion 5 Reporting Possible Violations 6 Avient Ethics Hotline 6 Protection from Retaliation 6 Antitrust Checklist 7 Quick Reference: Antitrust DO’s and DON’Ts 9 Guide For Compliance Avient is committed to promoting fair competition and free enterprise in the marketplace. Do not attend meetings with competitors (including trade association gatherings) at which prices or any of the foregoing subjects are discussed. 7. Even in the Antitrust Checklist 7 first instance, make every effort to verify and document the competing price prior to offering a distributor a lower price intended to meet that competitive price; do not, however, attempt to verify the competing price by contacting the competitor directly.

If the parties cannot agree upon and implement such changes within sixty (60) days after such notice, Seller shall thereupon have a right to terminate the relevant purchase order(s) forthwith by written notice to Buyer. 7. Si les parties ne réussissent pas à se mettre d'accord à ce sujet pour appliquer de tels changements dans les soixante (60) jours suivant cette notification, le Vendeur aura alors le droit de résilier la (les) commande(s) concernée(s) immédiatement par notification écrite à l'Acheteur. 7. PROTECTION DES DONNEES L'Acheteur accepte par les présentes que toute donnée - 7 - PAI-376900v1 version shall prevail against the French version. 18.

Five basic grip architectures, shown in Figure 7, can be used as a starting point for selecting the appropriate type of grip. 1. Figure 7: Basic grip architectures Ergonomic Grip Design Guide 7 CONTOURING involves shaping the grip to complement the architecture and intuitively guide the user to the proper posture and touchpoints. Top 10 Rules for Overmolded Components 1. .Match the chemistry of the TPE to the substrate for optimized bonding 2. .For new component designs, flow ratios (L/T) should be between 80:1 – 120:1 3. .Incorporate air vents between 0.0005" and 0.001" along the perimeter and/or at the end of fill 4. .Incorporate good flow shutoffs to prevent flashing 5. .Add surface texture to prevent sticking and to mask aesthetic defects 6. .Use a rigid substrate for easy ejection from the mold 7. .Ensure the TPE layer is thick enough to ensure good bonding.

Política global antimonopolio de Avient Actualizada: febrero de 2021 Índice Descripción general de la política 1 Descripción general de las leyes antimonopolio 2 Infracciones de leyes antimonopolio 3 Posibles áreas de preocupación antimonopolio 4 Conclusión 6 Informes de posibles infracciones 7 Línea Directa de Ética de Avient 7 Protección contra represalias 7 Lista de verificación antimonopolio 8 Referencia rápida: Qué hacer y qué no hacer en materia antimonopolio 10 Guía para el cumplimiento Avient se compromete a fomentar la competencia justa y la libre empresa en el mercado. Línea Directa de Ética https://www.Avient.com/company/policies-and- governance/ethics-hotline Teléfono en la Línea Directa de Ética: 1-877-228-5410 7 mailto:ethics.officer%40avient.com? No asista a reuniones con la competencia (incluidos encuentros de asociaciones comerciales) en las que se debatan precios o cualquiera de los temas anteriores. 7.

Глобальная антимонопольная политика компании Avient Содержание Общие сведения о политике 1 Общий обзор Антимонопольного законодательства США 2 Нарушения антимонопольного законодательства 3 Потенциальные проблемные области в сфере антимонопольного законодательства 3 Заключение 6 Фиксация возможных нарушений 7 Горячая линия по вопросам этики компании Avient 7 Защита от преследований 7 Контрольный список по соблюдению требований антимонопольного законодательства 8 Краткий справочник: Что следует и не следует делать в рамках антимонопольной политики 10 Руководство по нормативно- правовому соответствию Компания Avient привержена созданию справедливой конкуренции и свободного предпринимательства на рынке. Горячая линия по вопросам этики компании https://www.Avient.com/company/policies-and- governance/ethics-hotline телефону 1-877-228-5410 7 mailto:ethics.officer%40avient.com%20%20? Не присутствуйте на встречах с конкурентами (включая собрания торговых ассоциаций), где обсуждаются цены или любые упомянутые выше темы. 7.

Az Avient globális trösztellenes szabályzata Frissítve: 2021. február Tartalomjegyzék A szabályzat áttekintése 1 Az USA trösztellenes jogszabályainak áttekintése 2 A trösztellenes szabályok megsértése 3 Trösztellenes szempontból potenciálisan aggályos területek 4 Következtetés 6 Az irányelv lehetséges megsértéseinek jelentése 7 Avient etikai forródrót 7 Megtorlással szembeni védelem 7 Trösztellenes ellenőrzőlista 8 Gyors hivatkozás: Mit TEGYEN és mit NE TEGYEN a trösztellenes területen 10 Útmutató a megfelelőséghez Az Avient elkötelezett a tisztességes verseny és a szabad vállalkozás elősegítése iránt a piacon. Etikai forródrót https://www.Avient.com/company/policies-and- governance/ethics-hotline Telefonon: 1-877-228-5410 7 mailto:%20ethics.officer%40avient.com%20? Semmiképpen ne vegyen részt versenytársakkal (beleértve a szakmai szövetségeket is) tartott találkozókon, ahol az árakat vagy a fenti témák bármelyikét megvitatják. 7.

If the parties cannot agree upon and implement such changes within sixty (60) days after such notice, Seller shall thereupon have a right to terminate the relevant purchase order(s) forthwith by written notice to Buyer. 7. FORCE MAJEURE Either party may suspend performance hereunder (except to pay for the Product already received) in the event of: (1) acts of God, fire explosion, flood, hurricanes; (2) strikes, lockouts or other industrial disturbances or riots; (3) war, declared or undeclared; (4) compliance with any applicable law, regulation, order, or rule, foreign or domestic, including but not limited to, export license restrictions, priority, rationing, allocation or preemption orders or regulations, or cancellation of Seller's or Buyer's license to operate its manufacturing facilities; (5) shortage or other failure of facilities used for manufacture or transportation, shortage of labor, power, fuel or raw materials; (6) total or partial shutdown due to Seller's normal plant turnaround; or (7) any other cause or causes of any kind or character reasonably outside the control of the party failing to perform, whether similar or dissimilar from the enumerated causes (a "force majeure").

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 18 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% 450.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $39.28 April 4th, 2014 • 18 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 6 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 7 PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% Mix Shift Highlights Specialty Transformation Page 8 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 64% 0% 20% 40% 80% 2005 2008 2010 2013 Q1 2014 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $60M Target 2015 Target Proof of Performance & 2015 Goals Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid single digit revenue CAGR Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 11 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 42.0% 2006 Q1 2014 Healthcare Consumer Packaging and Additive Technology Transportation Page 12 Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Investing in operational and initiatives that drive profitability growth Manufacturing realignment  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?